In a very the latest research, we reported the identification as well as the characterization of a completely new atypical opioid receptor with distinctive adverse regulatory Houses in direction of opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is usually a